| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.32 | 0.07 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.27 | 0.07 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.085 | 0.08 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.08 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |